F S Pardo
Overview
Explore the profile of F S Pardo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
651
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pardo F, Hsu D, Zeheb R, Efird J, Okunieff P, Malkin D
Br J Cancer
. 2004 Oct;
91(9):1678-86.
PMID: 15494720
Abnormalities of the p53 tumor-suppressor gene are found in a significant proportion of astrocytic brain tumours. We studied tumour specimens from 74 patients evaluated over 20 years at the Massachusetts...
2.
Fitzek M, Thornton A, Harsh 4th G, Rabinov J, Munzenrider J, Lev M, et al.
Int J Radiat Oncol Biol Phys
. 2001 Aug;
51(1):131-7.
PMID: 11516862
Purpose: The role of dose escalation with proton/photon radiotherapy in lower-grade gliomas was assessed in a prospective Phase I/II trial. We report the results in terms of local control, toxicity,...
3.
Spear M, Breakefield X, Beltzer J, Schuback D, Weissleder R, Pardo F, et al.
Cancer Gene Ther
. 2001 Aug;
8(7):506-11.
PMID: 11498772
Phage display techniques rely on nearly random oligonucleotide sequences inserted into the protein III filament binding protein of an Escherichia coli filamentous phage M13 to generate a library of phage...
4.
Pardo F, Leon S, Carroll R, Black P, Atkins L
Cancer Genet Cytogenet
. 2001 Jul;
128(2):148-53.
PMID: 11463454
Despite decades of clinical data verifying the success of therapeutic approaches to human pituitary tumors, a significant number of tumors progress and can be life-threatening. The development of better therapeutic...
5.
Hug E, DeVries A, Thornton A, Munzenride J, Pardo F, Hedley-Whyte E, et al.
J Neurooncol
. 2000 Nov;
48(2):151-60.
PMID: 11083080
Objective: Atypical and malignant meningiomas are at high risk for local failure. The role of radiation therapy (RT) and dose levels required to improve tumor control are poorly defined. This...
6.
Aronen H, Pardo F, Kennedy D, Belliveau J, Packard S, Hsu D, et al.
Clin Cancer Res
. 2000 Jun;
6(6):2189-200.
PMID: 10873068
The purpose of this investigation was to elucidate the association between microvascular blood volume and glucose uptake and to link these measures with tumor angiogenesis. We demonstrate a regionally specific...
7.
Fitzek M, Thornton A, Rabinov J, Lev M, Pardo F, Munzenrider J, et al.
J Neurosurg
. 1999 Aug;
91(2):251-60.
PMID: 10433313
Object: After conventional doses of 55 to 65 Gy of fractionated irradiation, glioblastoma multiforme (GBM) usually recurs at its original location. This institutional phase II study was designed to assess...
8.
Aronen H, Niemi P, Kwong K, Pardo F, Davis T
Acta Radiol
. 1998 Oct;
39(5):474-81.
PMID: 9755693
Purpose: To study T1 relaxation times in brain tumors before and after paramagnetic contrast medium injection. Material And Methods: Seventeen patients with a known or suspected brain tumor were studied...
9.
Colvett K, Hsu D, Su M, Lingood R, Pardo F
Int J Radiat Oncol Biol Phys
. 1997 Jun;
38(3):463-8.
PMID: 9231667
Purpose: Meningiomas are common intracranial tumors, often well controlled with surgical resection alone. While the efficacy of radiation therapy in improving local control and progression-free survival is well documented, prognostic...
10.
Cosgrove G, Hochberg F, Zervas N, Pardo F, Valenzuela R, Chapman P
Neurosurgery
. 1997 Mar;
40(3):518-23; discussion 523-5.
PMID: 9055291
Objective: This report describes the clinical evaluation of a novel stereotactic radiosurgical device for interstitial irradiation of malignant brain tumors. Methods: Fourteen patients with cerebral lesions less than 3.5 cm...